The medications may help prevent further tissue damage after a heart attack (myocardial infarction), according to a new study ...

People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

Stopping GLP-1 medications is linked to a higher risk of heart attack, stroke, and death. Recent research found that even ...

One major benefit of taking injected GLP-1 medications is a sizeable reduction in risk for heart attacks, strokes and other heart problems.

Jabs like Wegovy and Ozempic may cut the risk of life-threatening complications after a heart attack, researchers have ...

A new study shows the heart health benefits of popular GLP-1 weight loss drugs may begin to fade soon after patients stop ...

Researchers have found that adults who stop taking GLP-1 receptor agonist drugs such as semaglutide and tirzepatide face a measurable increase in heart attack, stroke, and death risk within months of ...

Popular weight-loss drugs such as Ozempic, Wegovy, and Mounjaro may do more than help people shed pounds. New research suggests these GLP-1 medications could also help protect the heart after a heart ...

While these policies are meant to control health care costs by steering patients toward lower-priced alternatives, they may ...

A new study shows that popular weight‑loss drugs may help the heart after a person has a heart attack. These drugs are already used to help people lose weight or treat diabetes. Now researchers think ...

Clinical and payer strategies should treat GLP‑1 therapy as chronic for high-risk patients, addressing tolerability and cost ...